Endovascular Thrombectomy for Anterior Circulation Stroke
Author(s) -
Chester K. Yarbrough,
Charlene Ong,
Alexander Beyer,
Kim Lipsey,
Colin P. Derdeyn
Publication year - 2015
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.115.009847
Subject(s) - medicine , odds ratio , thrombolysis , modified rankin scale , stroke (engine) , randomized controlled trial , confidence interval , meta analysis , fibrinolytic agent , surgery , inclusion and exclusion criteria , intracerebral hemorrhage , tissue plasminogen activator , myocardial infarction , subarachnoid hemorrhage , ischemic stroke , ischemia , mechanical engineering , alternative medicine , pathology , engineering
Stroke affects ≈700,000 patients annually. Recent randomized controlled trials comparing endovascular thrombectomy (ET) with medical therapy, including intravenous thrombolysis (IVT) with tissue-type plasminogen activator, have shown effectiveness of ET for some stroke patients. The study objective is to evaluate the effect of ET on good outcome in stroke patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom